"A human doctor saves the individual, a veterinarian saves mankind"
- Louis Pasteur
4763 – the enzyme-linked immunosorbent assay (ELISA) for the quantitative determination of antibodies against Mycoplasma gallisepticum (MG)
M. gallisepticum is the most important pathogen of avian mycoplasmosis causing avian respiratory mycoplasmosis, an endemic infectious disease with a wide variety of clinical manifestations, from asymptomatic to severe ones.
The disease is included in the OIE list of diseases for which international trade imposes mandatory checks.
The prevention of avian mycoplasmosis is achieved by general and specific measures, the main objective being to obtain flocks that are free from Mycoplasma. General prevention relies on applying a set of measures such as: compliance with the rules of technology, hygiene and nutrition; the elimination of infectious diseases that may favour the emergence and evolution of mycoplasmosis; the purchase of the poultry material (eggs, chickens, replacement youth) from free farms; the clinical and morpho-pathological supervision of poultry flocks; the serological monitoring of flocks for breeding (grandparents and parents), followed by the removal of the serologically positive birds and the adequate treatment of serologically negative birds.
The serological exam seeks to detect specific antibodies of M. gallisepticum using ELISA immunoenzymatic techniques that meet the requirements of specificity and sensitivity.
gallinaceous bird blood serum
2 business days
quantitative determination of the antibodies against Mycoplasma gallisepticum from gallinaceous bird sera by way of the enzyme-linked immunosorbent ELISA assay, the indirect version